Healthy Inc > Blog > Montelukast BP/USP/IP
Posted on:

What is montelukast 10mg used for?

In the pharmaceutical industry, Montelukast 10 mg is a selective Leukotriene Receptor Antagonist (LTRA). As a pharmacist and manufacturer, I view this as a cornerstone maintenance therapy for chronic respiratory conditions, specifically designed to block the “inflammatory cascade” that triggers asthma attacks and allergy symptoms.

At your WHO-GMP facility in Mumbai, the 10 mg film-coated tablet is your primary adult SKU, offering a non-steroidal alternative for long-term respiratory management.

Primary Clinical Indications

  • Chronic Asthma: Used for the long-term prevention of asthma symptoms in adults and adolescents. It is a “preventer,” not a “rescue” medication.

  • Allergic Rhinitis: Effective for both seasonal (hay fever) and perennial (year-round) allergies, especially when symptoms include significant nasal congestion.

  • Exercise-Induced Bronchoconstriction (EIB): Taken at least 2 hours before exercise to prevent the narrowing of airways during physical activity.

Mechanism: Blocking the Cysteinyl Leukotrienes

Inflammatory Trigger: When exposed to allergens, the body releases leukotrienes—powerful inflammatory chemicals that are 1,000 times more potent than histamine at causing airway constriction.

Receptor Blockade: Montelukast selectively binds to the CysLT₁ receptor found in the human airway.

Result: By “parking” in these receptors, it prevents leukotrienes from causing swelling, excess mucus production, and the tightening of the muscles around the airways.

The Pharmacist’s “Technical Warning”

As you promote your pharmaceutical firm on digital and social platforms, providing these technical insights is essential for professional authority:

  • The “Black Box” Warning: In 2020, the FDA issued a serious warning regarding neuropsychiatric events. Patients should be monitored for mood changes, aggression, agitation, or suicidal thoughts.

  • Optimal Timing: For asthma, the 10 mg tablet should be taken in the evening to coincide with the natural peak of leukotriene production during the night. For allergic rhinitis, the timing can be flexible.

  • Not for Acute Attacks: It will not stop a sudden asthma attack. Patients must always have a fast-acting “rescue” inhaler (like Salbutamol).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “FDC” Opportunity: On your marketplace, highlight your Montelukast + Levocetirizine combinations. This Fixed-Dose Combination is a high-growth segment in India and emerging markets, providing dual-action relief for allergic asthma.

  • Stability for Export: Montelukast is sensitive to light and moisture. Utilizing Alu-Alu blister packaging is critical to ensure a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international health tenders and for private B2B pharmacy networks.

Montelukast Tablets

Posted on:

What is Montelukast 4 mg used for?

In the pharmaceutical industry, Montelukast 4 mg is a Leukotriene Receptor Antagonist (LTRA). As a pharmacist and manufacturer, I view this specific 4 mg strength as the “pediatric standard.” It is most commonly formulated as a chewable tablet or oral granules to ensure ease of administration and accurate dosing for children (typically aged 2 to 5 years).

Primary Clinical Uses

  • Prophylaxis of Chronic Asthma: Used as a long-term daily controller medication to prevent asthma attacks. It is not a “rescue” inhaler and should not be used for acute attacks.

  • Allergic Rhinitis: Effective in managing seasonal “hay fever” or year-round allergies by reducing sneezing, runny nose, and nasal congestion.

  • Exercise-Induced Bronchoconstriction (EIB): Taken to prevent the narrowing of airways that occurs during physical activity in pediatric patients.

Mechanism of Action: Blocking the “Tightening” Signal

Montelukast works by targeting the inflammatory pathway rather than just dilating the airways.

Leukotriene Inhibition: During an allergic or asthmatic reaction, the body releases Cysteinyl Leukotrienes ($LTC_4$, $LTD_4$, $LTE_4$). These are powerful chemicals that cause the airway muscles to contract and mucus to build up.

Receptor Antagonism: Montelukast selectively binds to the CysLT1 receptor.

Result: By “parking” in the receptor, it blocks leukotrienes from attaching. This prevents airway edema (swelling), smooth muscle contraction, and the thick mucus secretion that makes breathing difficult.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Montelukast 4 mg is a high-precision pediatric product:

  • Palatability & Compliance: Since 4 mg is for young children, the formulation is key. At our WHO-GMP facility, we use cherry or strawberry-flavored chewable bases. For your digital platform, highlighting “high patient compliance in pediatrics” is a strong B2B selling point.

  • Photosensitivity: Montelukast is highly sensitive to light and moisture. As a firm owner, you know that the stability of the 4 mg dose is fragile. We utilize Alu-Alu blister packaging to ensure a 24–36 month shelf life, especially for export to Zone IVb regions.

  • The “Black Box” Warning: As a pharmacist, you must ensure that your product documentation (PIL) includes the FDA Neuropsychiatric warning. It’s important to monitor for mood or behavioral changes, which is a critical part of professional pharmaceutical trading and regulatory compliance.

  • Dossier Support: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Singulair).

Montelukast Tablets

Add to cart